DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Pathways in cancer	R-HSA-9824443	map05200	dapsone	5215	drug-path
Olfactory transduction	R-HSA-9751605	map04740	dapsone	5215	drug-path
Acute myeloid leukemia	R-HSA-9680350	map05221	dapsone	5215	drug-path
VEGF signaling pathway	R-HSA-194138	map04370	dapsone	5215	drug-path
Bladder cancer	R-HSA-9700206	map05219	dapsone	5215	drug-path
ErbB signaling pathway	R-HSA-168638	map04012	dapsone	5215	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	dapsone	5215	drug-path
Endometrial cancer	R-HSA-2077421	map05213	dapsone	5215	drug-path
GnRH signaling pathway	R-HSA-168638	map04912	dapsone	5215	drug-path
Homologous recombination	R-HSA-5685942	map03440	dapsone	5215	drug-path
Shigellosis	0	map05131	dapsone	5215	drug-path
Pathogenic Escherichia coli infection	R-HSA-9609646	map05130	dapsone	5215	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	dapsone	5215	drug-path
Olfactory transduction	R-HSA-9751605	map04740	thiamphenicol	27200	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	thiamphenicol	27200	drug-path
Shigellosis	0	map05131	heptaminol	3590	drug-path
Pathogenic Escherichia coli infection	R-HSA-9609646	map05130	heptaminol	3590	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	heptaminol	3590	drug-path
Ubiquitin mediated proteolysis	R-HSA-983153	map04120	naltrexone	5360515	drug-path
Olfactory transduction	R-HSA-9751605	map04740	naltrexone	5360515	drug-path